product summary
Loading...
company name :
R&D Systems
product type :
other
product name :
Cultrex Spheroid Invasion Extracellular Matrix
catalog :
3500-096-03
quantity :
6 mL
price :
292 USD
more info or order :
R&D Systems product webpage
citations: 10
Reference
Wu Y, Li F, Yang C, Zhang X, Xue Z, Sun Y, et al. Super-enhancer-driven SLCO4A1-AS1 is a new biomarker and a promising therapeutic target in glioblastoma. Sci Rep. 2025;15:954 pubmed publisher
Zhang Y, Xi K, Fu Z, Zhang Y, Cheng B, Feng F, et al. Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse. Nat Commun. 2024;15:4241 pubmed publisher
Zhao H, Liu Y, Wang J, Wu C, Zhou X, Cai L, et al. Nuclear transport of phosphorylated LanCL2 promotes invadopodia formation and tumor progression of glioblastoma by activating STAT3/Cortactin signaling. J Adv Res. 2024;: pubmed publisher
Xue Z, Wang J, Wang Z, Liu J, Zhao J, Liu X, et al. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway. BMC Cancer. 2023;23:589 pubmed publisher
Tan C, Wei Y, Ding X, Han C, Sun Z, Wang C. Cell senescence-associated genes predict the malignant characteristics of glioblastoma. Cancer Cell Int. 2022;22:411 pubmed publisher
Mestre Farr xe0 s N, Guerrero S, Bley N, Rivero E, Coll O, Borr xe0 s E, et al. Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis. Nucleic Acids Res. 2022;50:8207-8225 pubmed publisher
Choi S, Lee Y, Shin K, Koo H, Kim D, Sa J, et al. Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma. Cell Death Dis. 2021;12:374 pubmed publisher
Voloshin T, Schneiderman R, Volodin A, Shamir R, Kaynan N, Zeevi E, et al. Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics. Cancers (Basel). 2020;12: pubmed publisher
Chi H, Tsai C, Wang C, Yang H, Lo C, Wang W, et al. DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/β-catenin signaling and cancer stem cell traits. Oncogene. 2020;39:5933-5949 pubmed publisher
Featherby S, Xiao Y, Ettelaie C, Nikitenko L, Greenman J, Maraveyas A. Low molecular weight heparin and direct oral anticoagulants influence tumour formation, growth, invasion and vascularisation by separate mechanisms. Sci Rep. 2019;9:6272 pubmed publisher
product information
master code :
3500-096-03
SKU :
3500-096-03
product name :
Cultrex Spheroid Invasion Extracellular Matrix
unit size :
6 mL
target :
Basement Membrane Extracts
category :
Cell Culture Products
species :
Multi-Species
top caption :
Spheroid Cell Invasion Assay_3500-096-K
USD :
292 USD
storage :
Product is stable for a minimum of 3 months from date of shipment. Store at û80 ░C; keep frozen. Dispense into working aliquots if needed; repeated freeze-thaws will destroy product integrity.
more info or order :
R&D Systems product webpage
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.